The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non‐small cell lung cancer

BACKGROUND: The recurrence rate of non‐small cell lung cancer (NSCLC) is as high as 30%, even in the cancer with pathological stage I disease. Therefore, identifying factors predictive of high‐risk pathological recurrence is important. However, few studies have examined the genetic status of these t...

Descripción completa

Detalles Bibliográficos
Autores principales: Honda, Takayuki, Seto, Katsutoshi, Endo, Satoshi, Takemoto, Akira, Tanimoto, Kousuke, Kobayashi, Masashi, Kitano, Masatake, Sakakibara, Rie, Mitsumura, Takahiro, Ishibashi, Hironori, Inazawa, Johji, Tanaka, Toshihiro, Miyazaki, Yasunari, Okubo, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587933/
https://www.ncbi.nlm.nih.gov/pubmed/37712717
http://dx.doi.org/10.1002/cam4.6535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587933/
https://www.ncbi.nlm.nih.gov/pubmed/37712717
http://dx.doi.org/10.1002/cam4.6535

Ejemplares similares